FDA Approved: RELEUKO — Original Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

FDA approved RELEUKO (filgrastim) from Amneal Pharmaceuticals LLC under an Original Application (BLA 761082).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Neutropenia
• Neutropenia

Drugs mentioned

• RELEUKO (FILGRASTIM)

Snippet

ORIG AP for RELEUKO (FILGRASTIM)